NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

0.6501
Delayed Data
As of Jul 02
 +0.0201 / +3.19%
Today’s Change
0.42
Today|||52-Week Range
1.30
+3.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-5.1M-7.0M-16.0M-15.2M
 
 
 
 
 
Depreciation425.0K341.0K314.0K232.0K
 
 
 
 
 
Total Other Cash Flow2.0M410.0K1.7M-636.0K
 
 
 
 
 
Funds From Operations-2.7M-6.3M-14.0M-15.6M
 
 
 
 
 
Funds From/For Other Operating Expenses472.0K252.0K-1.0M-543.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-3.1M-6.5M-13.0M-15.1M
 
 
 
 
 
 
InvestingIncrease In Investments-7.6M-4.9M-4.3M-4.0M
 
 
 
 
 
Decrease In Investments3.0M6.4M5.9M6.6M
 
 
 
 
 
Capital Expenditures-119.0K-148.0K-141.0K-68.0K
 
 
 
 
 
Fixed Asset Disposal0.006.0K0.00128.0K
 
 
 
Net Cash Flow Investing-4.7M1.4M1.4M2.6M
 
 
 
 
 
 
FinancingShort Term Borrowings71.0K-71.0K0.000.00
 
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale103.0K9.5M9.3M7.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing4.6M0.000.000.00
 
 
Other Uses - Financing106.0K0.000.000.00
 
 
Net Cash Flow - Financing4.7M9.5M9.3M7.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.00----
 
Net Change In Cash-3.1M4.3M-2.2M-5.1M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account